FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile

Clinicians now have two approved options for recurrent infections after antibiotic treatment.

Related Keywords

Boston ,Massachusetts ,United States ,Jessica Allegretti ,Joseph Thome ,Drug Administration On ,Reuters ,Colitis Center At Brigham Women Hospital ,Massachusetts Based Seres Therapeutics ,Drug Administration ,Colitis Center ,C Diff Infection ,Clostridium Difficile Infection ,Lostridium Difficile Associated Disease ,C Diff Associated Disease ,Bacteria ,Microbiome ,Large Intestinal ,Fecal Transplantation ,Stool Transplant ,Ecal Bacteriotherapy ,Fecal Microbiota Transplantation ,Mt ,Antibiotics ,Igecycline ,Biologic Therapy ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Diarrhea ,Abdomi ,